|
1
|
Ding LJ, Li Y, Wang SD, Wang XS, Fang F,
Wang WY, Lv P, Zhao DH, Wei F and Qi L: Long noncoding RNA
lncCAMTA1 promotes proliferation and cancer stem cell-like
properties of liver cancer by inhibiting CAMTA1. Int J Mol Sci.
17:16172016. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Gan HY, Li N, Zhang Q and Feng ZZ:
Silencing FOXA1 gene regulates liver cancer cell apoptosis and cell
proliferation. Eur Rev Med Pharmacol Sci. 22:397–404.
2018.PubMed/NCBI
|
|
3
|
Petruzziello A: Epidemiology of hepatitis
B virus (HBV) and Hepatitis C virus (HCV) related hepatocellular
carcinoma. Open Virol J. 12:26–32. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Robert J: Biology of cancer metastasis.
Bull Cancer. 100:333–342. 2013.(In French). View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Abdel-Misih SR and Bloomston M: Liver
anatomy. Surg Clin North Am. 90:643–53. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Lu WP and Dong JH: Hepatectomy for
hepatocellular carcinoma in the era of liver transplantation. World
J Gastroenterol. 20:9237–9244. 2014.PubMed/NCBI
|
|
7
|
Islami F, Miller KD, Siegel RL, Fedewa SA,
Ward EM and Jemal A: Disparities in liver cancer occurrence in the
United States by race/ethnicity and state. CA Cancer J Clin.
67:273–289. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Ye Y, Shen A and Liu A: Long non-coding
RNA H19 and cancer: A competing endogenous RNA. Bull Cancer.
106:1152–1159. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Fu XM, Guo W, Li N, Liu HZ, Liu J, Qiu SQ,
Zhang Q, Wang LC, Li F and Li CL: The expression and function of
long noncoding RNA lncRNA-ATB in papillary thyroid cancer. Eur Rev
Med Pharmacol Sci. 21:3239–3246. 2017.PubMed/NCBI
|
|
10
|
Misawa A, Takayama K, Urano T and Inoue S:
Androgen-induced long noncoding RNA (lncRNA) SOCS2-AS1 promotes
cell growth and inhibits apoptosis in prostate cancer cells. J Biol
Chem. 291:17861–17880. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Cui C, Zhai D, Cai L, Duan Q, Xie L and Yu
J: Long noncoding RNA HEIH promotes colorectal cancer tumorigenesis
via counteracting miR-939-mediated transcriptional repression of
Bcl-xL. Cancer Res Treat. 50:992–1008. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Wang H, Huo X, Yang XR, He J, Cheng L,
Wang N, Deng X, Jin H, Wang N, Wang C, et al: STAT3-mediated
upregulation of lncRNA HOXD-AS1 as a ceRNA facilitates liver cancer
metastasis by regulating SOX4. Mol Cancer. 16:1362017. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Jiao Y, Li Y, Ji B, Cai H and Liu Y:
Clinical value of lncRNA LUCAT1 expression in liver cancer and its
potential pathways. J Gastrointestin Liver Dis. 28:439–447. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Zhang Z, Wang S, Yang F, Meng Z and Liu Y:
LncRNA ROR1AS1 high expression and its prognostic significance in
liver cancer. Oncol Rep. 43:55–74. 2020.PubMed/NCBI
|
|
15
|
Li GH, Yu JH, Yang B, Gong FC and Zhang
KW: LncRNA LOXL1-AS1 inhibited cell proliferation, migration and
invasion as well as induced apoptosis in breast cancer via
regulating miR-143-3p. Eur Rev Med Pharmacol Sci. 23:10400–10409.
2019.PubMed/NCBI
|
|
16
|
Li W, Zhang B, Jia Y, Shi H, Wang H, Guo Q
and Li H: LncRNA LOXL1-AS1 regulates the tumorigenesis and
development of lung adenocarcinoma through sponging miR-423-5p and
targeting MYBL2. Cancer Med. 9:689–699. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Liu Y, Guo C, Li F and Wu L: LncRNA
LOXL1-AS1/miR-28-5p/SEMA7A axis facilitates pancreatic cancer
progression. Cell Biochem Funct. 38:58–65. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Li M, Cai O and Tan S: LOXL1-AS1 drives
the progression of gastric cancer via regulating miR-142-5p/PIK3CA
Axis. Onco Targets Ther. 12:11345–11357. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Xie N, Fei X, Liu S, Liao J and Li Y:
LncRNA LOXL1-AS1 promotes invasion and proliferation of
non-small-cell lung cancer through targeting miR-324-3p. Am J
Transl Res. 11:6403–6412. 2019.PubMed/NCBI
|
|
20
|
Kee KM, Wang JH, Lin CY, Wang CC, Cheng YF
and Lu SN: Validation of the 7th edition TNM staging system for
hepatocellular carcinoma: An analysis of 8,828 patients in a single
medical center. Dig Dis Sci. 58:2721–2728. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Li Z and Zhang H: Reprogramming of
glucose, fatty acid and amino acid metabolism for cancer
progression. Cell Mol Life Sci. 73:377–392. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Zhao J, Bai X, Feng C, Shang X and Xi Y:
Long non-coding RNA HCP5 facilitates cell invasion and
epithelial-mesenchymal transition in oral squamous cell carcinoma
by miR-140-5p/SOX4 Axis. Cancer Manag Res. 11:10455–10462. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Wang J, Zhang C, Wu Y, He W and Gou X:
Identification and analysis of long non-coding RNA related miRNA
sponge regulatory network in bladder urothelial carcinoma. Cancer
Cell Int. 19:3272019. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Denny SK, Yang D, Chuang CH, Brady JJ, Lim
JS, Grüner BM, Chiou SH, Schep AN, Baral J, Hamard C, et al: Nfib
promotes metastasis through a widespread increase in chromatin
accessibility. Cell. 166:328–342. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Liu J, Zhai C, Liu D and Liu J: The long
noncoding RNA LOXL1-AS1 promotes the proliferation, migration, and
invasion in hepatocellular carcinoma. Anal Cell Pathol (Amst).
2020:41820922020.PubMed/NCBI
|
|
27
|
Yang X, Xing G, Liu S, Li B, He Y and Wang
F: LncRNA LOXL1-AS1 promotes endometrial cancer progression by
sponging miR-28-5p to upregulate RAP1B expression. Biomed
Pharmacother. 125:1098392020. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Xue F, Xu YH, Shen CC, Qin ZL and Zhou HB:
Non-coding RNA LOXL1-AS1 exhibits oncogenic activity in ovarian
cancer via regulation of miR-18b-5p/VMA21 axis. Biomed
Pharmacother. 125:1095682020. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Meng Q and Lan D: A review on
muscle-specific microRNAs as the biomarker for Duchenne muscular
dystrophy. Zhongguo Dang Dai Er Ke Za Zhi. 21:1148–1152. 2019.(In
Chinese). PubMed/NCBI
|
|
30
|
He J, Zhao H, Deng D, Wang Y, Zhang X,
Zhao H and Xu Z: Screening of significant biomarkers related with
prognosis of liver cancer by lncRNA-associated ceRNAs analysis. J
Cell Physiol. 235:2464–2477. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Zhang B, Zhou M, Zou L, Miao J, Wang Y, Li
Y, Lu S and Yu J: Long non-coding RNA LOXL1-AS1 acts as a ceRNA for
miR-324-3p to contribute to cholangiocarcinoma progression via
modulation of ATP-binding cassette transporter A1. Biochem Biophys
Res Commun. 513:827–833. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Long B, Li N, Xu XX, Li XX, Xu XJ, Liu JY
and Wu ZH: Long noncoding RNA LOXL1-AS1 regulates prostate cancer
cell proliferation and cell cycle progression through miR-541-3p
and CCND1. Biochem Biophys Res Commun. 505:561–568. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Tang L, Yang B, Cao X, Li Q, Jiang L and
Wang D: MicroRNA-377-3p inhibits growth and invasion through
sponging JAG1 in ovarian cancer. Genes Genomics. 41:919–926. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Wang X, Chen T, Zhang Y, Zhang N, Li C, Li
Y, Liu Y, Zhang H, Zhao W, Chen B, et al: Long noncoding RNA
Linc00339 promotes triple-negative breast cancer progression
through miR-377-3p/HOXC6 signaling pathway. J Cell Physiol.
234:13303–13317. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Ell B and Kang Y: Transcriptional control
of cancer metastasis. Trends Cell Biol. 23:603–611. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Wilczynska KM, Singh SK, Adams B, Bryan L,
Rao RR, Valerie K, Wright S, Griswold-Prenner I and Kordula T:
Nuclear factor I isoforms regulate gene expression during the
differentiation of human neural progenitors to astrocytes. Stem
Cells. 27:1173–1181. 2009. View
Article : Google Scholar : PubMed/NCBI
|
|
37
|
Wu C, Zhu X, Liu W, Ruan T, Wan W and Tao
K: NFIB promotes cell growth, aggressiveness, metastasis and EMT of
gastric cancer through the Akt/Stat3 signaling pathway. Oncol Rep.
40:1565–1573. 2018.PubMed/NCBI
|
|
38
|
Sun L, Fang Y, Wang X, Han Y, Du F, Li C,
Hu H, Liu H, Liu Q, Wang J, et al: miR-302a inhibits metastasis and
cetuximab resistance in colorectal cancer by targeting NFIB and
CD44. Theranostics. 9:8409–8425. 2019. View Article : Google Scholar : PubMed/NCBI
|
